Effective October 31, 2025: Clinical Policies
Date: 08/01/25
Wellcare By Allwell has approved policies to ensure medical necessity review criteria is current and appropriate for members and the scope of services provided. As a result the following policies are effective on October 31, 2025, at 12:00AM.
POLICY | APPLICABLE PRODUCTS | NEW POLICY OVERVIEW OR UPDATED POLICY REVISIONS |
Allogeneic Hematopoietic Proginator Cell Therapy (MC.CP.MP.249) | Wellcare By Allwell (Medicare) | Policy updates include:
|
Skin and Soft Tissue Substitutes for Chronic Wounds (MC.CP.MP.185) | Wellcare By Allwell (Medicare) | Policy updates include:
|
To review all policies, please visit Medicare Prior Authorization Clinical Policies webpage.
Prior to updates, the policies were approved for use by the Medicare Quality Committee.
For questions or additional information, please contact Wellcare By Allwell Provider Services at HMO: 1-800-977-7522 DSNP: 1-877-935-8023.